RDUS

Radius Health, Inc. [RDUS] Stock Forecast

Q: What is Radius Health, Inc. stock symbol ?

Radius Health, Inc. is a US stock, located in Waltham of Massachusetts and trading under the symbol RDUS

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

RDUS Stock Summary

The Moving Average Convergence Divergence (MACD) for RDUS recently turned positive (within last 10 days).

Unstable dividend track record

Top 10 Correlated ETFs

RDUS

Top 10 Correlated Stocks

RDUS

In the News

RDUS Financial details

Company Rating

Market Cap

485.25M

Income

-25.97M

Revenue

2.96B

Book val./share

Cash/share

Dividend

0.56

Dividend %

2.06%

Employees

293

Optionable

Shortable

Yes

Earnings

09 Aug 2022

P/E

73.88

Forward P/E

PEG

-6.41

P/S

0.25

P/B

0.82

P/C

P/FCF

24.91

Quick Ratio

0.88

Current Ratio

1.93

Debt / Equity

LT Debt / Equity

EPS (TTM)

-0.92

EPS next Y

EPS next Q

EPS this Y

-115.31%

EPS next Y

EPS next 5Y

EPS last 5Y

-20.46%

Revenue last 5Y

75.46%

Revenue Q/Q

-6.27%

EPS Q/Q

-30.43%

SMA20

11.12%

SMA50

-19.82%

SMA100

-25.94%

Inst Own

Inst Trans

ROA

ROE

ROC

0.02%

Gross Margin

10%

Oper. Margin

Profit Margin

Payout

204%

Shs Outstand

Shs Float

Target Price

52W Range

17.0-36.64

52W High

-61.92%

52W Low

-19.35%

RSI

55.02

Rel Volume

0.76

Avg Volume

213.81K

Volume

163.16K

Perf Week

0.44%

Perf Month

6.44%

Perf Quarter

-10.1%

Perf Half Y

-6.61%

Beta

0.51647

Volatility

0.18%, 0.61%

Prev Close

-1.08%

Price

13.71

Change

1.26%

RDUS Financial Performance

RDUS Dividend History

RDUS Frequently Asked Questions

What is Radius Health, Inc. stock symbol ?

Radius Health, Inc. is a US stock , located in Waltham of Massachusetts and trading under the symbol RDUS

What is Radius Health, Inc. stock quote today ?

Radius Health, Inc. stock price is $13.71 today.

Is Radius Health, Inc. stock public?

Yes, Radius Health, Inc. is a publicly traded company.

Something similar

Top by Market Cap

FXAIX

Company Profile

Volume Average 213.81K
Market Capitalization 485.25M
Employee 293
CEO Mr. Jesper Hoiland
Headquarters Waltham,MASSACHUSETTS,US
IPO Date 2014-06-06
Website https://radiuspharm.com

Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a transdermal system that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone-receptor positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts. As of August 10, 2022, Radius Health, Inc. was taken private.